Document Classification

Section Type: RESULTS

Text: However, an interaction was detected between fenretinide treatment and menopausal status in both outcomes (P for interaction in both outcomes =. 045), with a possible beneficial effect in premenopausal women (contralateral breast cancer : adjusted hazard ratio [HR] = 0. 66, and 95 % confidence interval [CI] = 0. 41-1. 07 ; ipsilateral breast cancer : adjusted HR = 0. 65, and 95 % CI = 0. 46-0. 92) and an opposite effect in postmenopausal women (contralateral breast cancer : adjusted HR = 1. 32, and 95 % CI = 0. 82-2. 15 ; ipsilateral breast cancer : adjusted HR = 1. 19, and 95 % CI = 0. 75-1. 89).